241. 高チロシン血症1型 Hypertyrosinemia type I Clinical trials / Disease details

臨床試験数 : 14 / 薬物数 : 7 - (DrugBank : 1) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 5

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-002286-36-DE (EUCTR)	19/11/2012	03/08/2012	Taste and palatability of Orfadin suspension.	Taste and palatability of Orfadin suspension. An open, non-controlled 3-day study in pediatric patie ...	Hereditary tyrosinemia type 1 (HT-1) MedDRA version: 14.1;Level: LLT;Classification code 10069459;Te ...	Product Name: Orfadin oral suspension 4mg/ml INN or Proposed INN: Nitisinone	Swedish Orphan Biovitrum AB	NULL	Not Recruiting			Female: yes Male: yes	18		Germany;United Kingdom
2	EUCTR2012-002286-36-GB (EUCTR)	04/10/2012	10/08/2012	Taste and palatability of Orfadin suspension.	Taste and palatability of Orfadin suspension. An open, non-controlled 3-day study in pediatric patie ...	Hereditary tyrosinemia type 1 (HT-1) MedDRA version: 14.1;Level: LLT;Classification code 10069459;Te ...	Product Name: Orfadin oral suspension 4mg/ml INN or Proposed INN: NITISINONE	Swedish Orphan Biovitrum AB	NULL	Not Recruiting			Female: yes Male: yes	18		Germany;United Kingdom

First Previous1Next Last